Who is sponsoring NCT03942133?

NCT03942133 is sponsored by Peking Union Medical College Hospital.

What drugs are being tested in NCT03942133?

Interventions in NCT03942133: ultrasound-guided short-axis placement of catheter at the entrance of the adductor canal, ultrasound-guided long-axis placement of catheter at the middle of the adductor canal.

What condition does NCT03942133 study?

NCT03942133 studies Total Knee Arthroplasty, Analgesia, Nerve Block.

Is NCT03942133 still recruiting?

NCT03942133 is currently completed. Last updated 2 January 2020.

Last reviewed 2020-01-02 · How we verify

NCT03942133

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tow Techniques of Adductor Canal Block for Analgesia After Total Knee Replacement

Completed NA Last updated 2 January 2020

What this trial tests

NA trial testing ultrasound-guided short-axis placement of catheter at the entrance of the adductor canal in Total Knee Arthroplasty in 62 participants. Completed in 16 December 2019.

Timeline

11 May 2019

Primary endpoint
8 December 2019

16 December 2019

Quick facts

Lead sponsor	Peking Union Medical College Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	supportive care
Enrollment	62
Start date	11 May 2019
Primary completion	8 December 2019
Estimated completion	16 December 2019
Sites	1 location across China

Drugs / interventions tested

ultrasound-guided short-axis placement of catheter at the entrance of the adductor canal
ultrasound-guided long-axis placement of catheter at the middle of the adductor canal

Conditions studied

Total Knee Arthroplasty — all drugs for Total Knee Arthroplasty →
Analgesia — all drugs for Analgesia →
Nerve Block — all drugs for Nerve Block →

Sponsor

Peking Union Medical College Hospital

Who can join

Adults 18 to 80, any sex, with Total Knee Arthroplasty or Analgesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study compares the tow technique of continues adductor canal block for total knee replacement surgery. Half participants will receive catheterization at the entrance of the adductor canal, while the other half will receive catheterization at the middle point of the adductor canal.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Continuous block at the proximal end of the adductor canal provides better analgesia compared to that at the middle of the canal after total knee arthroplasty: a randomized, double-blind, controlled trial.
Fei Y, Cui X, Chen S, Peng H, et al · · 2020 · cited 12× · PMID 33036554 · DOI 10.1186/s12871-020-01165-w
Continuous Block at the Proximal End of the Adductor Canal Provides Better Analgesia Compared to that at the Middle of the Canal After Total Knee Arthroplasty: A Randomized, Double-blind, Controlled Trial
Fei Y, cui x, Chen S, Peng H, et al · · 2020 · DOI 10.21203/rs.3.rs-41785/v2

Verify or expand the search:

Other recruiting trials for Total Knee Arthroplasty

Currently open trials in the same condition.

NCT07524387 — Femoral Triangle Block vs Adductor Canal Block on Early Quadriceps Function After Total Knee Arthroplasty · NA · recruiting
NCT07511842 — REST-Knee: A Pilot RCT of 72-Hour Knee Immobilization and Pain Outcomes · NA · recruiting
NCT07324954 — Methylene Blue in Total Knee Arthroplasty (TKA) · Phase 1 · recruiting
NCT07336160 — ERAS-Based Preoperative Nutrition and Fasting in Total Knee Arthroplasty · NA · recruiting
NCT07371390 — Minimal Sedation During Knee Replacement Surgery · NA · recruiting

Other Peking Union Medical College Hospital trials

Trials by the same sponsor.

NCT07466251 — PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke · Phase 4 · not yet recruiting
NCT06743321 — Speech-to-speech Voice-cloning Care (SVCC) to Improve ICU-acquired Anxiety for Critically Ill Patients · NA · not yet recruiting
NCT07590336 — 68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma · Phase 1, PHASE2 · not yet recruiting
NCT07515976 — Mapping of Genomic Structural Variations in Major Birth Defects · not yet recruiting
NCT07386756 — Early Precise Identification and Intervention Strategies for Individuals at High Risk of Prediabetes · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03942133 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking Union Medical College Hospital
Last refreshed: 2 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03942133.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing